Skip to main content

Posters

Recent Posters

Posters  —  21 February Feb 2024

Correlation of Anti-DFS70 Autoantibodies by ELISA with HEp-2 Cells DFS Pattern by IFA

Read More about Correlation of Anti-DFS70 Autoantibodies by ELISA with HEp-2 Cells DFS Pattern by IFA
Posters  —  21 February Feb 2024

Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples

Read More about Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept and Certolizumab Pegol, in 63,930 Patient Samples
Posters  —  21 February Feb 2024

Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores

Read More about Novel Markers for Rheumatoid Arthritis, Anti-CarP, Anti-Sa, and Anti-CEP1, Are More Frequently Positive and Higher in Titer in RA Patients with Higher Vectra® Disease Activity Scores
Posters  —  20 February Feb 2024

Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens

Read More about Correlation of Anti-Centromere Antibodies (ACA) Detection by Indirect Immunofluorescence (IFA) on HEp-2 Cells and by ELISA Demonstrates High Concordance but Highlights Advantage of IFA in Detecting ACA to All Centromere Protein (CENP) Antigens
Posters  —  14 February Feb 2024

20 critical questions for ensuring inhaled crop protection and chemical registration

Read More about 20 critical questions for ensuring inhaled crop protection and chemical registration
Posters  —  5 February Feb 2024

Implementation of Laboratory Automation to Support Scaling of Cancer Patients Testing using OmniSeq® INSIGHT Molecular Diagnostic Test

Read More about Implementation of Laboratory Automation to Support Scaling of Cancer Patients Testing using OmniSeq® INSIGHT Molecular Diagnostic Test
Posters  —  5 February Feb 2024

Fully Automated Extraction of High-Quality Total Nucleic Acids from FFPE Specimens using Covaris truXTRAC® FFPE SMART Solutions & Hamilton Robotics

Read More about Fully Automated Extraction of High-Quality Total Nucleic Acids from FFPE Specimens using Covaris truXTRAC® FFPE SMART Solutions & Hamilton Robotics
Posters  —  5 February Feb 2024

Automated Tissue Dissection Solution to Support Comprehensive Genomic and Immune Profiling

Read More about Automated Tissue Dissection Solution to Support Comprehensive Genomic and Immune Profiling
Posters  —  11 December Dec 2023

Findings of clinically significant variants (Tier IA) with comprehensive genomic profiling in a breast cancer patient cohort

Read More about Findings of clinically significant variants (Tier IA) with comprehensive genomic profiling in a breast cancer patient cohort
Posters  —  11 December Dec 2023

Comprehensive immune profiling reveals factors associated with neoadjuvant chemotherapy response in triple negative breast cancer

Read More about Comprehensive immune profiling reveals factors associated with neoadjuvant chemotherapy response in triple negative breast cancer
Posters  —  17 November Nov 2023

Non-V600 BRAF mutated melanomas have immune microenvironments primed for immune checkpoint inhibitor response

Read More about Non-V600 BRAF mutated melanomas have immune microenvironments primed for immune checkpoint inhibitor response
Posters  —  17 November Nov 2023

Genomic stability of prostate cancers with homologous recombination gene alterations

Read More about Genomic stability of prostate cancers with homologous recombination gene alterations